A detailed history of Two Sigma Securities, LLC transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 19,316 shares of LUCD stock, worth $26,656. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,316
Holding current value
$26,656
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$0.76 - $1.08 $14,680 - $20,861
19,316 New
19,316 $15,000
Q2 2024

Aug 14, 2024

BUY
$0.67 - $1.04 $18,594 - $28,863
27,753 New
27,753 $22,000

Others Institutions Holding LUCD

About Lucid Diagnostics Inc.


  • Ticker LUCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 38,568,500
  • Market Cap $53.2M
  • Description
  • Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...
More about LUCD
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.